This translation has been automatically generated and has not been verified for accuracy.VBI Vaccines Inc said on Monday it had entered into an agreement with Canada to develop a potential vaccine for COVID-19 by 2022 through midstage trials conducted exclusively in the country.
Canada will contribute around 75 per cent of the U.S.-based company’s development costs and $55.9-million for the project. VBI Vaccines said last month that together with the National Research Council Canada it was investigating the vaccine candidate, VBI-2900, in preclinical trials.As per the agreement, signed last week, the company’s Ottawa-based unit is obligated to complete the vaccine development in or before the first quarter of 2022.
There are currently no approved vaccines for COVID-19, but around 38 vaccines are being tested in humans around the world. Health authorities can explain the scientific knowledge about how COVID-19 spreads and how to stop it, and governments can enforce rules on some public activities, Dr. Theresa Tam says, but ultimately each of us is responsible for making decisions to keep ourselves and others from getting sick.
😅
2022? Wow, I can’t wait to this one coming!
2022 ? JustinTrudeau have you lost your mind?
Have you ever paid your contractor up front? Yeah..
A vaccine that killed only 0.6% of those infected!
2022? WTF is that going to do for anyone?